NEXTCELL
Live / Applied — Non-final action written — not yet mailed (as of 06 Mar 2026)
What this means for you
Not registered yet, but its 17 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437475
- Mark type
- Stylized text
- Filed
- 17 Oct 2025
Goods and services
- Class 001 — Chemicals: Chemicals used in science; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for scientific use; biological preparations [other than for medical use]; cultures of cell media [other than for medical or veterinary use].
- Class 042 — Scientific and technological services: Science and technology services; research services; scientific research and development; medical and pharmacological research services; laboratory services; analytical laboratory services; scientific services relating to the isolation and cultivation of human tissues and cells; consultancy in the field of scientific research; advisory services relating to scientific research; providing information about industrial analysis and research services; research laboratories; provision of information relating to scientific research; research and development of new products for others; scientific research for medical purposes; laboratory research services relating to pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; clinical trials; culturing of cells for scientific research purposes; stem cell research; quality control and authentication services; providing scientific research information in the field of genetics; providing medical research information in the field of genetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical research services; development of pharmaceutical preparations and medicines; pharmaceutical products development.
Owner
Prosecution history
- 07 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 06 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 21 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB